Literature DB >> 22057257

An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis.

Maisam Abu-El-Haija1, Marek Sinkora, David K Meyerholz, Michael J Welsh, Paul B McCray, John Butler, Aliye Uc.   

Abstract

BACKGROUND/AIMS: In cystic fibrosis (CF), pancreatic disease begins in utero and progresses over time to complete destruction of the organ. Although inflammatory cells have been detected in the pancreas of humans and pigs with CF, their subtypes have not been characterized.
METHODS: Using four-color flow cytometry, we analyzed the surface antigens of leukocytes in pancreas, blood, and mesenteric lymph nodes (MLN) of newborn pigs with CF (CFTR(-/-) and CFTR(Δ)(F508/)(Δ)(F508)) and in those without CF (CFTR(+/-), CFTR(+/)(Δ)(F508), CFTR(+/+)). Pancreatic histopathology was examined with HE stain.
RESULTS: CF pig pancreas had patchy distribution of inflammatory cells with neutrophils/macrophages in dilated acini, and lymphocytes in the interstitium compared to non-CF. B cells, effector (MHC-II(+)) and cytotoxic (CD2(+)CD8(+)) γδ T cells, activated (MHC-II(+) and/or CD25(+)) and effector (CD4(+)CD8(+)) αβ T helper cells, effector natural killer cells (MHC-II(+)CD3(-)CD8(+)), and monocytes/macrophages and neutrophils were increased in the CF pig pancreas compared to pigs without CF. Blood and MLN leukocyte populations were not different between CF and non-CF pigs.
CONCLUSIONS: We discovered an activated immune response that was specific to the pancreas of newborn CF pigs; inflammation was not systemic. The presence of both innate and adaptive immune cells suggests that the disease process is complex and extensive.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057257      PMCID: PMC3224519          DOI: 10.1159/000332582

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  49 in total

1.  Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis.

Authors:  R E Hunger; C Mueller; K Z'graggen; H Friess; M W Büchler
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Phenotype of porcine monocytic cells: modulation of surface molecule expression upon monocyte differentiation into macrophages.

Authors:  K C McCullough; R Schaffner; V Natale; Y B Kim; A Summerfield
Journal:  Vet Immunol Immunopathol       Date:  1997-09-19       Impact factor: 2.046

3.  Summary of workshop findings for antibodies reacting with porcine T-cells and activation antigens: results from the Second International Swine CD Workshop.

Authors:  M D Pescovitz; B K Book; B Aasted; J Dominguez; A Ezquerra; I Trebichavsky; B Novikov; I Valpotic; L Sver; J Nielsen; S Arn; D H Sachs; J K Lunney; P C Boyd; J Walker; R Lee; W Davis; I R Barbosa; F Zuckermann; A Saalmüller
Journal:  Vet Immunol Immunopathol       Date:  1998-01-30       Impact factor: 2.046

4.  Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis.

Authors:  Emanuela M Bruscia; Ping-Xia Zhang; Ayano Satoh; Christina Caputo; Ruslan Medzhitov; Ambika Shenoy; Marie E Egan; Diane S Krause
Journal:  J Immunol       Date:  2011-05-18       Impact factor: 5.422

5.  Phenotypic classification of porcine lymphocyte subpopulations in blood and lymphoid tissues.

Authors:  H Yang; R M Parkhouse
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

6.  Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis.

Authors:  L L Clarke; B R Grubb; S E Gabriel; O Smithies; B H Koller; R C Boucher
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

7.  An animal model for cystic fibrosis made by gene targeting.

Authors:  J N Snouwaert; K K Brigman; A M Latour; N N Malouf; R C Boucher; O Smithies; B H Koller
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

8.  Immune protection and control of inflammatory tissue necrosis by gamma delta T cells.

Authors:  Y X Fu; C E Roark; K Kelly; D Drevets; P Campbell; R O'Brien; W Born
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

9.  Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency.

Authors:  R T Couper; M Corey; D J Moore; L J Fisher; G G Forstner; P R Durie
Journal:  Pediatr Res       Date:  1992-08       Impact factor: 3.756

10.  Generation of antibody- and B cell-deficient pigs by targeted disruption of the J-region gene segment of the heavy chain locus.

Authors:  M Mendicino; J Ramsoondar; C Phelps; T Vaught; S Ball; T LeRoith; J Monahan; S Chen; A Dandro; J Boone; P Jobst; A Vance; N Wertz; Z Bergman; X-Z Sun; I Polejaeva; J Butler; Y Dai; D Ayares; K Wells
Journal:  Transgenic Res       Date:  2010-09-26       Impact factor: 2.788

View more
  14 in total

Review 1.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

2.  The role of CFTR in transepithelial liquid transport in pig alveolar epithelia.

Authors:  James F Collawn; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-13       Impact factor: 5.464

3.  Pancreatic and biliary secretion are both altered in cystic fibrosis pigs.

Authors:  Aliye Uc; Radhamma Giriyappa; David K Meyerholz; Michelle Griffin; Lynda S Ostedgaard; Xiao Xiao Tang; Marwa Abu-El-Haija; David A Stoltz; Paula Ludwig; Alejandro Pezzulo; Maisam Abu-El-Haija; Peter Taft; Michael J Welsh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-30       Impact factor: 4.052

4.  Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways.

Authors:  Maisam Abu-El-Haija; Shyam Ramachandran; David K Meyerholz; Marwa Abu-El-Haija; Michelle Griffin; Radhamma L Giriyappa; David A Stoltz; Michael J Welsh; Paul B McCray; Aliye Uc
Journal:  Am J Pathol       Date:  2012-06-08       Impact factor: 4.307

5.  Mapping of long-range INS promoter interactions reveals a role for calcium-activated chloride channel ANO1 in insulin secretion.

Authors:  Zhixiong Xu; Gaelle M Lefevre; Oksana Gavrilova; Mark B Foster St Claire; Gregory Riddick; Gary Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

Review 6.  Animal and model systems for studying cystic fibrosis.

Authors:  Bradley H Rosen; Marc Chanson; Lara R Gawenis; Jinghua Liu; Aderonke Sofoluwe; Alice Zoso; John F Engelhardt
Journal:  J Cyst Fibros       Date:  2017-09-19       Impact factor: 5.482

Review 7.  Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.

Authors:  Alicia K Olivier; Katherine N Gibson-Corley; David K Meyerholz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

Review 8.  Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.

Authors:  Ziying Yan; Zoe A Stewart; Patrick L Sinn; John C Olsen; Jim Hu; Paul B McCray; John F Engelhardt
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-12       Impact factor: 5.032

Review 9.  Cigarette smoke and CFTR: implications in the pathogenesis of COPD.

Authors:  Andras Rab; Steven M Rowe; S Vamsee Raju; Zsuzsa Bebok; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-09       Impact factor: 5.464

10.  Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.

Authors:  Aliye Uc; Alicia K Olivier; Michelle A Griffin; David K Meyerholz; Jianrong Yao; Maisam Abu-El-Haija; Katherine M Buchanan; Oriana G Vanegas Calderón; Marwa Abu-El-Haija; Alejandro A Pezzulo; Leah R Reznikov; Mark J Hoegger; Michael V Rector; Lynda S Ostedgaard; Peter J Taft; Nick D Gansemer; Paula S Ludwig; Emma E Hornick; David A Stoltz; Katie L Ode; Michael J Welsh; John F Engelhardt; Andrew W Norris
Journal:  Clin Sci (Lond)       Date:  2015-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.